Indian life sciences companies are seeking acquisitions in the US and Europe in the chemistry and custom synthesis space.
Financial Express
Tuesday 22 April 2008
Indian companies shopping for CMOs
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2008
(457)
-
▼
April
(49)
- Goodwin Biotechnology has completed expansion of i...
- FDA asks for cash
- Dr Reddy's buys US facility
- SOCMA criticises call for US-REACH
- ProBioGen has begun a biologics manufacturing tech...
- Angel's Estonian deal
- DSM expects its Pharmaceutical Products business t...
- FDA calls on pharma to oversee quality
- NPIL sees custom manufacturing revenue rise 15% in...
- Archimica sells plant, completes turnaround
- Lonza has settled the GS Gene Expression system le...
- Record quarter for SAFC
- Jubilant sees 38% sales increase in year to end Ma...
- FDA weak on foreign inspections
- Pfizer to cut more manufacturing
- Evonik confirms bidders
- Albemarle sees 4% drop in Q1 fine chemicals sales
- Indian companies shopping for CMOs
- Penn Pharmaceuticals has opened a suite for manufa...
- Origin labels for drugs proposed
- DSM Biologics will optimise Upfront Chromatography...
- Senators: FDA underfunded
- Analysts suggest Clariant and Ciba are takeover ta...
- AZ to outsource all manufacturing
- FDA to open China office in May
- Sumitomo will be the exclusive sales agent for Chi...
- Laureate Pharma to manufacture Alopexx Pharmaceuti...
- Codexis files for IPO
- Almac facility under threat from waste plant
- Evonik plans chemicals acquisitions
- Actavis buys in China
- CMC ICOS Biologics will manufacture the lead molec...
- Farmaceutici-Formentiwill manufacture betahistine ...
- Laureate Pharma to manufacture Cytheris’ Interleuk...
- Overhaul coming for FDA
- Calls for FDA to label products with origin of ing...
- India faces pharma manufacturing threat from China
- FDA to hire
- Jubilant buys Draxis
- Atrium Innovations will sell its active ingredient...
- Archimica is expanding capacity for cryogenic prod...
- Carbogen adds high potency in India
- Schering-Plough to cut manufacturing
- Evonik bidders named
- Lonza to expand nicotinate capacity
- PharmAthene has completed its acquisition of Aveci...
- Evonik field down to four
- Alpharma has completed the sale of its API busines...
- Dowpharma sells UK assets
-
▼
April
(49)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment